Business, energy, technology, markets and global industry news from Business News Today

eyonis LCS

PharmaDeviceNews eyonis LCS
Median Technologies and Olea Medical are partnering to expand commercial deployment of eyonis LCS, an artificial intelligence-assisted lung cancer screening platform designed to support radiologists reviewing low-dose chest computed tomography scans. Representative image.
Medical Devices & Diagnostics

Can Canon Medical’s imaging reach turn eyonis LCS regulatory success into hospital adoption?

Median Technologies and Olea Medical will deploy eyonis LCS across United States and European lung cancer screening workflows.

Read More
Can eyonis LCS deliver real-world impact beyond regulatory milestones in lung cancer screening
Medical Devices & Diagnostics

What FDA clearance means for Median Technologies eyonis LCS in a crowded AI radiology market

Median Technologies advances eyonis LCS after FDA clearance. Discover what this means for AI lung cancer screening and European expansion.

Read More